5-HT 2c agonists (Boehringer Ingelheim/Evotec)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT 2c agonists (Boehringer Ingelheim/Evotec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim International GmbhEvotec SE
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A